Showing results (91-100 of 166) with videos related to
Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcomeSatyendra C Tripathi, Haley L Peters, Ayumu Taguchi, et al.Cancer Research|May 20, 2016
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung CancerMauricio S Caetano, Huiyuan Zhang, Amber M Cumpian, et al.Nature Communications|September 10, 2020
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustionDavid H Peng, Bertha Leticia Rodriguez, Lixia Diao, et al.Thorax|November 26, 2018
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM stagingElena Martínez-Terroba, Carmen Behrens, Jackeline Agorreta, et al.The Journal of Molecular Diagnostics : JMD|May 17, 2017
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic AcidMeenakshi Mehrotra, Rajesh R Singh, Wei Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancersAlexander Augustyn, Mark Borromeo, Tao Wang, et al.The Journal of Clinical Investigation|January 12, 2018
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Priyam Banerjee, Xin Liu, et al.International Journal of Molecular Sciences|February 24, 2024
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung AdenocarcinomaMei-Chee Tai, Leonidas E Bantis, Gargy Parhy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.Carcinogenesis|July 1, 2020
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancerShanshan Deng, Marco Ramos-Castaneda, Walter V Velasco, et al.Pageof 17